Related references
Note: Only part of the references are listed.Colorectal Cancer Survival: An Analysis of Patients With Metastatic Disease Synchronous and Metachronous With the Primary Tumor
Rajiv Kumar et al.
CLINICAL COLORECTAL CANCER (2014)
Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer
Y. R. B. M. van Gestel et al.
EJSO (2014)
Addition of Biological Therapies to Palliative Chemotherapy Prolongs Survival in Patients With Peritoneal Carcinomatosis of Colorectal Origin
Yvonne L. B. Klaver et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2013)
Is There a Possibility of a Cure in Patients With Colorectal Peritoneal Carcinomatosis Amenable to Complete Cytoreductive Surgery and Intraperitoneal Chemotherapy?
Diane Goere et al.
ANNALS OF SURGERY (2013)
The tumour biology of synchronous and metachronous colorectal liver metastases: a systematic review
A. A. P. Slesser et al.
CLINICAL & EXPERIMENTAL METASTASIS (2013)
Modest advances in survival for patients with colorectal-associated peritoneal carcinomatosis in the era of modern chemotherapy
Sabino Zani et al.
JOURNAL OF SURGICAL ONCOLOGY (2013)
Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer
J. Segelman et al.
BRITISH JOURNAL OF SURGERY (2012)
An Update on the Current and Emerging Targeted Agents in Metastatic Colorectal Cancer
Edward Chu
CLINICAL COLORECTAL CANCER (2012)
Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy
Y. L. B. Klaver et al.
EJSO (2012)
Treatment of Colorectal Peritoneal Carcinomatosis With Systemic Chemotherapy: A Pooled Analysis of North Central Cancer Treatment Group Phase III Trials N9741 and N9841
Jan Franko et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach?
Paul H. Sugarbaker et al.
LANCET ONCOLOGY (2012)
Current Status and Future Directions in the Treatment of Peritoneal Dissemination from Colorectal Carcinoma
Dominique Elias et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2012)
An update on chemotherapy of colorectal liver metastases
Chen-Chen Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Population-based survival of patients with peritoneal carcinomatosis from colorectal origin in the era of increasing use of palliative chemotherapy
Y. L. B. Klaver et al.
ANNALS OF ONCOLOGY (2011)
Influence of Modern Systemic Therapies as Adjunct to Cytoreduction and Perioperative Intraperitoneal Chemotherapy for Patients With Colorectal Peritoneal Carcinomatosis: A Multicenter Study
Terence C. Chua et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
A Systematic Review and Meta-Analysis of Cytoreductive Surgery with Perioperative Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Origin
Christopher Cao et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Long-Term Results of Cytoreduction and HIPEC Followed by Systemic Chemotherapy
Vic J. Verwaal
CANCER JOURNAL (2009)
Complete Cytoreductive Surgery Plus Intraperitoneal Chemohyperthermia With Oxaliplatin for Peritoneal Carcinomatosis of Colorectal Origin
Dominique Elias et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Addition of bevacizurnab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: Results of a randomized phase II trial
FF Kabbinavar et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Bevacizurnab in combination with fluorouracil and leucovorin: An active regimen for first-line metastatic colorectal cancer
HI Hurwitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Peritoneal carcinomatosis from colorectal cancer
DG Jayne et al.
BRITISH JOURNAL OF SURGERY (2002)
Share Paper
